BRENDA MACDONALD: Open Payments
NPI 1831940444 · AMHERST, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$961 in 47 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $613 · 2025 $961
Food & beverage: $961
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $262 |
| AstraZeneca Pharmaceuticals LP | 12 | $217 |
| Novo Nordisk Inc | 5 | $128 |
| Amgen Inc. | 4 | $93 |
| Vanda Pharmaceuticals Inc. | 2 | $63 |
| PFIZER INC. | 3 | $51 |
| Exact Sciences Corporation | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Organon LLC | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: QULIPTA, AIRSUPRA, Ozempic, BREZTRI, OTEZLA, VRAYLAR, FANAPT, UBRELVY.
Industry payments across NH — which companies pay providers there.
